ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Ovarian Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near San Antonio, TX, USA:

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer (KOMODO-1)

kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults with advanced or metastatic breast ...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: BBI-940

Phase 1

Boundless Bio, Inc.

San Antonio, Texas, United States and 7 other locations

standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...

Enrolling
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Capecitabine
Drug: PCS6422 and capecitabine

Phase 2

Processa Pharmaceuticals

San Antonio, Texas, United States and 12 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

San Antonio, Texas, United States of America and 10 other locations

with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...

Active, not recruiting
Breast Cancer
Drug: Zelenectide pevedotin (BT8009)

Phase 2

BicycleTx

San Antonio, Texas, United States and 17 other locations

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Active, not recruiting
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

San Antonio, Texas, United States and 34 other locations

growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to:* Learn how well...

Enrolling
Breast Cancer
Drug: Tucatinib
Drug: Doxil

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 7 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

San Antonio, Texas, United States and 78 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Active, not recruiting
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

San Antonio, Texas, United States and 32 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Active, not recruiting
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States of America and 57 other locations

growth factor 2 negative (ER+/HER2-) locally advanced or metastatic breast cancer. The main goals of this study are to:* Identify t...

Active, not recruiting
Breast Cancer
Drug: AC699

Phase 1

Accutar Biotechnology

San Antonio, Texas, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems